VBY329 is designed for the prevention of Respiratory Syncytial Virus (RSV) infections in newborns, infants, and children, and results from Invivyd’s proprietary antibody discovery technology ...

VTx-002 is described as a first-in-class vectorised antibody targeting molecular pathways involving TAR DNA-binding protein ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced updated data from the LOTIS-7 Phase 1b open-label ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint ...

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...

Full Study Results Expected in Q1 2026Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early ...

Korea’s Celltrion is continuing to think bigger than biosmilars, this time securing the option to use TriOar’s antibody ...

Automated pipette-based Protein A micro-purification is fast, accurate, and less expensive than traditional purification methods.

AD is a progressive, relentless disease with Aß and tau as hallmarks. It is caused by a continuous underlying neurotoxic process driven by PF that begins before amyloid plaque accumulation and ...

Meanwhile, Mercado Envíos (the logistics network) provides faster shipping that boosts customer satisfaction and incentivizes ...